• SeekInCure™

    Pan-cancer Recurrence monitoring

    SeekInCureTM is the first-in-class blood-based pan-cancer recurrence monitoring test.

    A panoramic view of cancer genomic landscape

    cfDNA detection via NGS builds cacer genomic landscape view

    Cutting-edge multivariate algrithm

    Genomics combines with proteomics,capture the signal of cancer recurrence

    Multidimensional fingerprint

    CNA、Fragmentation and protein markers discover the law of cancer molecule recurrence

    Big date and Artificial intelligence

    CRI model constructed by machine learning evaluates the risk of cancer recurrence precisely

    Specifications

    Indicated subjects: cancer patients amendable to radical resection
    Sample requirement: 10ml post-op peripheral blood

    TAT:10 working days

    Results readout: CRI (cancer recurrence index)
    Sampling time:

  •  

    Test Workflow

     
    1

    Pre-test inquiry

    2

    Informed consent

    3

    Blood-draw

    4

    Testing

    5

    Analyzing + Interpretation

    6

    Reporting

    7

    Post-test inquiry

    所有文章
    ×

    ©2018 SeekIn Cancer. All Rights Reserved.